Aequus Pharmaceuticals Inc (AQS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
64
About the Report
About the Report
Summary
Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company's pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Pharmaceuticals develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. The company offers its products to hospital specialty markets including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas across Canada. It offers its products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.
Aequus Pharmaceuticals Inc (AQS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Aequus Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14
Partnerships 15
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Licensing Agreements 22
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Equity Offering 25
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Acquisition 38
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc-Key Competitors 39
Aequus Pharmaceuticals Inc-Key Employees 40
Aequus Pharmaceuticals Inc-Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42
Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44
Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47
Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49
May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51
May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52
Product News 54
09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54
04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55
02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56
Product Approvals 57
Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus' Anti-Nausea Patch 57
Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58
Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59
Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60
Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61
Clinical Trials 62
Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62
Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
List of Figure
List of Figures
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises USD 1.2 Million In First Round Of Venture Financing 14
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc, Key Competitors 39
Aequus Pharmaceuticals Inc, Key Employees 40
Aequus Pharmaceuticals Inc, Subsidiaries 41
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.